The CD28 stromal LI showed a statistically significant difference in the invasive front (p = 0.002; Table 2), as well as in the tumor core (p = 0.001; Table 2), with higher values in cSCC than in BCC cases. This evidence concerns the gene CD28 and neoplasm.